Liquid Biopsy clinical trials at UCSF
1 research study open to eligible people
Liquid biopsy uses blood samples to detect cancer cells. UCSF is investigating how opening the blood-brain barrier can make liquid biopsies more effective for brain tumors. This study is focused on individuals with glioblastoma.
Showing trials for
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects with GlioBlastoma Brain Tumors
open to eligible people ages 18-80
The purpose of this study is to evaluate the safety and efficacy of targeted blood brain barrier disruption with Exablate Model 4000 Type 2.0/2.1 for liquid biopsy in subjects with suspected Glioblastoma brain tumors
San Francisco, California and other locations
Last updated: